THE DEAL, AT A GLANCE
From the announcementGlasgow Biotech Mironid
01Who is involvedBacked by an industry-experienced management team, supported by a strong advisory network, blue-chip investors including Roche Venture Fund, Epidarex CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedGlasgow Biotech Mironid raised Series B, announced 2026-08-05From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersGlasgow Biotech Mironid's $34M Series B is a below-median but institutionally supported Healthcare & Life Sciences financing in an active 30-day sector funding tape.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Glasgow Biotech Mironid · Financing Record
Explore source-linked visual explanations for Glasgow Biotech Mironid. Unsupported claims are withheld while source review continues.
Record 9663 · Recorded date: 2026-08-05
Explore company records →